Cargando…
High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis
BACKGROUND: Selenium (Se) is an essential trace element with antioxidant, anti-inflammatory, and immunomodulatory effects. So far, several randomized clinical trials (RCTs) have demonstrated that parenteral Se may improve clinical outcomes in intensive care unit (ICU) patients. Since publication of...
Autores principales: | Manzanares, William, Lemieux, Margot, Elke, Gunnar, Langlois, Pascal L., Bloos, Frank, Heyland, Daren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084353/ https://www.ncbi.nlm.nih.gov/pubmed/27788688 http://dx.doi.org/10.1186/s13054-016-1529-5 |
Ejemplares similares
-
Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2015) -
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2016) -
Intravenous fish oil lipid emulsions in ICU patients: an updated systematic review and meta-analysis
por: Langlois, P, et al.
Publicado: (2015) -
Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?
por: Heyland, Daren K
Publicado: (2007) -
Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials
por: Elke, Gunnar, et al.
Publicado: (2016)